Toxicology and pharmacokinetic study of orally administered 5-iodo-2-pyrimidinone-2'deoxyribose (IPdR) x 28 days in Fischer-344 rats: impact on the initial clinical phase I trial design of IPdR-mediated radiosensitization.

Saved in:

Bibliographic Details
Title:	Toxicology and pharmacokinetic study of orally administered 5-iodo-2-pyrimidinone-2'deoxyribose (IPdR) x 28 days in Fischer-344 rats: impact on the initial clinical phase I trial design of IPdR-mediated radiosensitization.
Authors:	Kinsella TJ (AUTHOR), Kinsella MT (AUTHOR), Hong S (AUTHOR), Johnson JP (AUTHOR), Burback B (AUTHOR), Tosca PJ (AUTHOR), Kinsella, Timothy J¹ (AUTHOR), Kinsella, Michael T (AUTHOR), Hong, Seongwon (AUTHOR), Johnson, Jerry P (AUTHOR), Burback, Brian (AUTHOR), Tosca, Patricia J (AUTHOR)
Source:	Cancer Chemotherapy & Pharmacology. Feb2008, Vol. 61 Issue 2, p323-334. 12p.
Database:	Academic Search Ultimate

Description
ISSN:	03445704